Search
  1. Home
  2. Southern Africa
  3. South Africa
  • News

Researchers say US vaccine too expensive

    JOHANNESBURG

    The South African HIV/AIDS Vaccine Initiative (SAAVI) on Friday put to rest rumours that South Africa is eager to buy an American HIV/AIDS vaccine.

    SAAVI said it would be too costly for the government to purchase the vaccine, despite it having already completed phase-3 human trials.

    "To make the vaccine compatible with the HIV subtype prevalent to South Africa would be equivalent to starting over again," SAAVI head of media and communications, Michelle Galloway, told the UN news service PlusNews.

    Galloway stressed that the vaccine was only effective on the B-strand of the virus, the subtype most common in the US. If the vaccine were to be used locally, it would have to be adapted at great cost for the local C-strand.

    "We are not aware of any negotiations between the government and the US," Galloway added.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join